Molecular epidemiology of respiratory syncytial virus in pediatric patients in a six-year period;Epidemiología molecular del virus sincicial respiratorio en pacientes pediátricos en un período de seis años

Acta Bioquimica Clinica Latinoamericana

Volumn 45, Issue 1, 2011, Pages 3-45

  Viegas, Mariana ^a  

^a Hospital de Niños   (Spain)

Author keywords

Argentina *; Human respiratory syncytial virus *; Molecular epidemiology *; Phylodinamic *; Seasonality *; Sixty nucleotide duplication

Indexed keywords

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS;

EID: 79960965097     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (175)

1. Weissenbacher M, Carballal G, Avila M, Salomón H, Harisiadi J, Catalano M, et al. Etiologic and clinical evaluation of acute lower respiratory tract infections in young Argentinean children: an overview. Rev Infect Dis 1990; 12:S889-S898.
2. Straliotto SM, Siqueira MM, Muller RL, Fischer GB, Cunha ML, Nestor SM. Viral etiology of acute respiratory infections among children in Porto Alegre, RS, Brazil. Rev Soc Bras Med Trop 2002; 35:283-91. (Pubitemid 34822875)
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15.
4. Barrero PR, Viegas M, Valinotto LE, Mistchenko AS. Genetic and phylogenetic analyses of Influenza A H1N1pdm in Buenos Aires, Argentina. J Virol 2010. In press.
5. Benguigui Y, López Antumaño FJ, Schmunis G, Yunes J, eds. Organización Panamericana de la Salud, Washington D.C., 1997.
6. Carballal G, Videla CM, Espinosa MA, Savy V, Uez O, Sequeira M, et al. Multicentered study of viral acute lower respiratory infections in children from four cities of Argentina, 1993-1994. J Med Virol 2001; 64: 167-74.
7. Mahony JB. Detection of respiratory viruses by molecular methods. Clin Microbiol Rev 2008; 21: 716-47.
8. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-24. (Pubitemid 32588029)
9. Heikkinen T, Osterback R, Peltola V, Jartti T, Vainionpää R. Human metapneumovirus infections in children. Emerg Infect Dis 2008; 14:101-6.
10. Kaplan NM, Dove W, Abd-Eldayem SA, Abu-Zeid AF, Shamoon HE, Hart CA. Molecular epidemiology and disease severity of respiratory syncytial virus in relation to other potential pathogens in children hospitalized with acute respiratory infection in Jordan. J Med Virol 2008; 80:168-74. (Pubitemid 350220103)
11. Fleming DM, Pannell RS, Cross KW. Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health 2005; 59:586-90. (Pubitemid 40904786)
12. Cooper DL, Smith GE, Edmunds WJ, Joseph C, Gerard E, George RC. The contribution of respiratory pathogens to the seasonality of NHS Direct calls. J Infect 2007; 55: 240-8. (Pubitemid 47260302)
13. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev 2003; 4: 105-11.
14. López Guinea J, Casado Flores M, Sobrino M, Espínola Docio B, de la Calle Cabrera T, Serrano A, et al. Bronquiolitis grave. Epidemiología y evolución de 284 pacientes. An Pediatr (Barc) 2007; 67: 116-22. (Pubitemid 47282222)
15. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991; 133:1135-51.
16. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986; 140: 543-6. (Pubitemid 16120909)
17. Murry AR, Dowell SF. Respiratory syncytial virus: Not just for kids. Hosp Pract 1997; 32: 87-8, 91-84, 98 passim.
18. Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100-3. (Pubitemid 11046430)
19. Bitko V, Musiyenko A, Barik S. Viral infection of the lungs through the eye. J Virol 2007; 81: 783-90. (Pubitemid 46067904)
20. Graman PS, Hall CB. Epidemiology and control of nosocomial viral infections. Infect Dis Clin North Am 1989; 3: 815-41.
21. Bont L. Nosocomial RSV infection control and outbreak management. Paediatr Respir Rev 2009; 10 Suppl 1: 16-7.
22. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas GR Jr. Respiratory syncytial virus infections within families. N Engl J Med 1976; 294: 414-9.
23. Clarke SKR, Gardner PS, Poole PM. Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas: Research Council subcommittee on respiratory syncytial virus vaccines. Br Med J 1978; 2: 796-8. (Pubitemid 9009026)
24. Navas L, Wang E, de Carvalho V, Robinson J. Improved outcome of respiratory syncytial virus infection in a highrisk hospitalized population of Canadian children: Pediatric Investigative Collaborative Network on Infections in Canada. J Pediatr 1992; 121: 348-54.
25. Organización Panamericana de la Salud. Salud en las Américas 2007: Vol II - Argentina. Washington, US.
26. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med 2007; 28: 222-42. (Pubitemid 46676916)
27. Lindblom A, Bhadri V, Söderhäll S, Ohrmalm L, Wong M, Norbeck, et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol 2010; 47: 234-7.
28. Murata Y, Falsey AR. Respiratory syncytial virus infection in adults. Review Antivir Ther 2007; 12: 659-70. (Pubitemid 47235508)
29. Galiano MC, Palomo C, Videla CM, Arbiza J, Melero JA, Carballal G. Genetic and antigenic variability of human respiratory syncytial virus (groups a and b) isolated over seven consecutive seasons in Argentina (1995 to 2001). J Clin Microbiol 2005; 43: 2266-73. (Pubitemid 40656239)
30. da Silva LH, Spilki FR, Riccetto AG, de Almeida RS, Baracat EC, Arns CW. Genetic variability in the G protein gene of human respiratory syncytial virus isolated from the Campinas metropolitan region, Brazil. J Med Virol 2008; 80: 1653-60.
31. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009; 9:291-300.
32. Meert K, Heidemann S, Lieh-Lai M, Sarnaik AP. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 1989; 7: 167-70.
33. Maffey AF, Barrero PR, Venialgo C, Fernández F, Fuse VA, Saia M, et al. Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children. Pediatr Pulmonol 2010; 45:619-25.
34. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332: 133-8.
35. McBride JT. Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J Pediatr 1999; 135: S28-S32. (Pubitemid 30176781)
36. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-5. (Pubitemid 29381367)
37. Cane P. Molecular epidemiology of respiratory syncytial virus. Rev Med Virol 2001; 11: 103-16. (Pubitemid 32267781)
38. Hall CB, Douglas RG Jr, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293: 1343-6.
39. Aherne W, Bird T, Court SDM, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23: 7-18.
40. Gardner PS, McQuillin J, Court SDM. Speculation on pathogenesis in death from respiratory syncytial virus infection. Br Med J 1970; 1: 327-30.
41. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol 2002; 76: 5654-66. (Pubitemid 34517916)
42. Hoffman SJ, Laham FR, FP Polack. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect 2004; 6:767-72. (Pubitemid 38781189)
43. Openshaw PJM Tregoning JS. 2005. Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection . Clin Microbiol Rev; 18: 541-55. (Pubitemid 40995115)
44. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalances in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168: 633-9. (Pubitemid 37175965)
45. Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2003; 188: 904-7. (Pubitemid 37176038)
46. Awomoyi AA, Rallabhandi P, Pollin TI, Lorenz E, Sztein MB, Boukhvalova MS, et al. Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children. J Immunol 2007; 179: 3171-7.
47. Murphy BR, Olmsted RA, Collins PL, Chanock RM, Prince GA. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J Virol 1988; 62:3907-10.
48. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr, Boyce TG, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000; 182:1331-42.
49. Henrickson KJ, Hall CB. Diagnostic Assays for Respiratory Syncytial Virus Disease. Pediatr Infect Dis J 2007; 26: S36-S40. (Pubitemid 350295028)
50. Henrickson KJ. Advances in the laboratory diagnosis of viral respiratory disease. Pediatr Infect Dis J 2004; 23:S6-S10. (Pubitemid 38168905)
51. Falsey AR, McCann RM, Hall WJ, Criddle MM. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults. J Am Geriatr Soc 1996; 44: 71-3. (Pubitemid 26017770)
52. Rodriguez WJ. Management strategies for respiratory syncytial virus infections in infants. J Pediatr 1999; 135: 45-50.
53. Chen CH, Lin YT, Yang YH, Wang LC, Lee JH, Kao CL, et al. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol 2008; 19: 166-72.
54. Teng MN, Whitehead SS, Bermingham A, St Claire M, Elkins WR, Murphy BR, et al. Recombinant respiratory syncytial virus that does not express theNS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol 2000; 74:9317-21.
55. Schmidt AC, Wenzke DR, McAuliffe JM, St Claire M, Elkins WR, Murphy BR, et al. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone. J Virol 2002; 76:1089-99. (Pubitemid 34066413)
56. Connors M, Collins PL, Firestone CY, Murphy BR. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J Virol 1991; 65: 1634-7.
57. Cherrie AH, Anderson K, Wertz GW, Openshaw PJ. Human Cytotoxic TCells Stimulated by Antigen on Dendritic Cells Recognize the N, SH, F, M, 22k, and 1b Proteins of Respiratory Syncytial Virus. J Virol 1992; 66: 2102-10.
58. Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 2001; 20: S27-S31. (Pubitemid 32925004)
59. Plotnicky H, Siegrist CA, Aubry JP, Bonnefroy JY, Corvaia N, Nguyen TN, et al. Enhanced pulmonary immunopathology following neonatal priming with formalininactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine 2003; 21: 2651-60. (Pubitemid 36561358)
60. Kalina WV, Wollums AR, Berghaus RD, Gershwin LJ. Formalin- inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle. Vaccine 2004; 22: 1465-74. (Pubitemid 38446923)
61. Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, et al. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 2009; 15: 34-41
62. Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, et al. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine 2007; 25: 7372-8. (Pubitemid 47484016)
63. Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis 2005; 191: 1093-104. (Pubitemid 40404368)
64. de Waal L, Power UF, Yuksel S, van Amerongen G, Nguyen TN, Niesters HG, et al. Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge. Vaccine 2004; 22: 915-22. (Pubitemid 38221085)
65. Nokes JD, Cane PA. New strategies for control of respiratory syncytial virus infection. Curr Opin Infect Dis 2008; 21:639-43.
66. Zhao X, Chen FP, Sullender WM. Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats. Virology 2004; 318: 608-12. (Pubitemid 38224303)
67. Zhao X, Sullender WM. In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol 2005; 79: 3962-8. (Pubitemid 40388336)
68. Wu H, Pfarr DS, Tang Y, An LL, Patel NK, Watkins JD, et al. Ultra-potent antibodies against respiratory syncytial virus: Effects of binding kinetics and binding valence on viral neutralization. J Mol Biol 2005; 350: 126-44. (Pubitemid 40804737)
69. Blount RE Jr, Morris JA, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coriza. Proc Soc Exp Biol Med 1956; 92:544-9.
70. Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illnes of a virus related to Cimpanzees coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg 1957; 66: 281-90.
71. Chanock R, Finberg L. Recovery from infants with respiratory illnes of a virus related to Cimpanzees coryza agent (CCA). II. Epidemiologic aspects of infection of infants and young children. Am J Hyg 1957; 66: 291-300.
72. Roberts ShR, Compans RW, Wertz GW. Respiratory Syncytial Virus Matures at the Apical Surfaces of polarized epithelial cells. J Virol 1995; 69: 2667-73.
73. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-28. (Pubitemid 32553362)
74. Collins PL, Hill MG, Camargo E, Grosfeld H, Chanock RM, Murphy BR. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5́ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. PNAS 1995; 92: 11563-7.
75. Mink MA, Stec DS, Collins PL. Nucleotide sequences of the 39 leader and 59 trailer regions of human respiratory syncytial virus genomic RNA. Virology 1991; 185: 615-24.
76. Cowton VM, McGivern DR, Fearns R. Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol 2006; 87: 1805-21. (Pubitemid 43985864)
77. Johnson PR, Collins PL. The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA. J Gen Virol 1989; 70: 1539-47. (Pubitemid 19165615)
78. Ramaswamy M, Shi L, Varga SM, Barik S, Behlke MA, Look DC. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006; 344: 328-39. (Pubitemid 43049621)
79. Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, Look DC, et al. Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF- B-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth. J Virol 2007; 81: 1786-95. (Pubitemid 46214452)
80. Garcia-Barreno B, Delgado T, Melero JA. Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: Significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J Virol 1996; 70: 801-8.
81. Fearns R, Peeples ME, Collins PL. Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 1997; 236: 188-201. (Pubitemid 27410366)
82. Dupuy LC, Dobson S, Bitko V, Barik S. Casein kinase 2- mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; Phosphorylation by casein kinase 1 occurs mainly at Ser (215) and is without effect. J Virol 1999; 73: 8384-92. (Pubitemid 29441700)
83. Horikami SM, Curran J, Kolakofsky D, Moyer SA. Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 1992; 66: 4901-08.
84. Collins PL, Hill MG, Johnson PR. The two open reading frames of the 22K mRNA of human respiratory syncytial virus: Sequence comparison of antigenic subgroups A and B and expression in vitro. J Gen Virol 1990; 71: 3015-20.
85. Fearns R, Collins PL. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol 1999; 73: 5852-64. (Pubitemid 29274872)
86. Bermingham A, Collins PL. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. PNAS 1999; 96: 11259-64. (Pubitemid 29487368)
87. Stec DS, Hill MG, Collins PL. Sequence analysis of the polymerase L gene of human respiratory syncytial virus and predicted phylogeny of nonsegmented negativestrand viruses. Virology 1991; 183: 273-87.
88. Henderson G, Murray J, Yeo RP. Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology 2002; 300: 244-54.
89. Ghildyal R, Li D, Peroulis I, Shields B, Bardin PG, Teng MN, Collins PL, et al. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein J Gen Virol 2005; 86: 1879-84. (Pubitemid 40916370)
90. Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol 2002; 83: 753-7. (Pubitemid 34284858)
91. Collins PL, Mottet G. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. J Gen Virol 1993; 74: 1445-50. (Pubitemid 23230266)
92. Techaarpornkul S, Barretto N, Peeples ME. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol 2001; 75: 6825-34. (Pubitemid 32641568)
93. Perez M, Garcia-Barreno B, Melero JA, Carrasco L, Guinea R. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology 1997; 235: 342-51. (Pubitemid 27394347)
94. Fuentes S, Tran KC, Luthra P, Teng MN, He B. Function of the Respiratory Syncytial Virus Small Hydrophobic Protein. J Virol 2007; 81: 8361-6. (Pubitemid 47101523)
95. Collins PL, Mottet G. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 1991; 72: 3095-101.
96. Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 1999; 254: 81-91. (Pubitemid 29391716)
97. Hemminway BR, Yu Y, Tanaka Y, Perrine KG, Gustafson E, Bernstein JM, et al. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology 1994; 200: 801-5.
98. Schlender J, Zimmer G, Herrler G, Conzelmann KK. Respiratory Syncytial Virus (RSV) Fusion Protein Subunit F2, Not Attachment Protein G, Determines the Specificity of RSV Infection. J Virol 2003; 77: 4609-16. (Pubitemid 36402810)
99. Olmsted RA, Elango N, Prince G, Murphy BR, Johnson PR, Moss B et al. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contribution of the F and G glycoproteins to host immunity. PNAS 1986; 83: 7462-6. (Pubitemid 16000542)
100. Kim YK, Choi EH, Lee HJ. Genetic Variability of the Fusion Protein and Circulation Patterns of Genotypes of the Respiratory Syncytial Virus. J Med Virol 2007; 79: 820-8.
101. López JA, Bustos R, Orvell C, Berois M, Arbiza J, García-Barreno B, et al. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol 1998; 72: 6922-8. (Pubitemid 28324018)
102. Levine S, Klaiber-Franco R, Paradiso PR. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 1987; 68: 2521-4. (Pubitemid 17129228)
103. Roberts SR, Lichtenstein D, Ball LA, Wertz GW. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol 1994; 68: 4538-46. (Pubitemid 24183050)
104. Wertz GW, Krieger M, Ball LA. Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O glycosylation. J Virol 1989; 63: 4767-76. (Pubitemid 19257855)
105. Wathen MW, Aeed PA, Elhammer AP. Characterization of oligosaccharide structures on a chimeric respiratory syncytial virus protein expressed in insect cell line Sf9. Biochemistry 1991; 30: 2863-8.
106. Gorman JJ, Ferguson BL, Speelman D, Mills J. Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrixassisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci 1997; 6: 1308-15. (Pubitemid 27260390)
107. Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulfate proteoglycans. Biochem J 1986; 236: 313-25. (Pubitemid 16036974)
108. Feldman SA, Hendry RM, Beeler JA. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 1999; 73: 6610-6617. (Pubitemid 29327843)
109. Wertz GW, Moudy RM. Antigenic and genetic variation in human respiratory syncytial virus. Pediatr Infect Dis J 2004; 23(Suppl 1):S19-24. (Pubitemid 38168907)
110. Johnson PR Jr, Olmsted RA, Prince GA, Murphy BR, Alling DW, Walsh EE, et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: Evaluation of the contributions of F and G glycoproteins to immunity. J Virol 1987; 61: 3163-6.
111. Johnson PR, Spriggs MK, Olmsted RA, Collins PL. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins. PNAS 1987; 84: 5625-9.
112. Martinez I, Dopazo J, Melero JA. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 1997; 78: 2419-29. (Pubitemid 27469982)
113. Trento A, Galiano M, Videla C, Carballal G, García-Barreno B, Melero JA, et al. Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol 2003; 84: 3115-20. (Pubitemid 37336796)
114. Cane PA, Pringle CR. Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J Virol 1995; 69: 2918-25.
115. Srinivasakumar N, Ogra PL, Flanagan TD. Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol 1991; 65: 4063-9.
116. Hardy RW, Wertz GW. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol 1998; 72: 520-6. (Pubitemid 28048867)
117. Krempl C, Murphy BR, Collins PL. Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions. J Virol 2002; 76: 11931-42. (Pubitemid 35304293)
118. Cheng X, Park H, Zhou H, Jin H. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J Virol 2005; 79: 13943-52. (Pubitemid 41552693)
119. Cowton VM, McGivern DR, Fearns R. Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol 2006; 87: 1805-21 (Pubitemid 43985864)
120. McCurdy LH, Graham BS. Role of Plasma Membrane Lipid Microdomains in Respiratory Syncytial Virus Filament Formation. J Virol 2003; 77: 1747-56. (Pubitemid 36109986)
121. Arsla?agic E, Matsumoto M, Suzuki K, Nerome K, Tsutsumi H, Hung T. Maturation of respiratory syncytial virus within HEp-2 cell cytoplasm. Acta Virol 1996; 40: 209-14. (Pubitemid 26419774)
122. Coates HV, Alling DW, Chanock RM. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization assay. Am J Epidemiol 1966; 83: 299-313.
123. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, Stone Y, et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 1985; 151:626-33. (Pubitemid 15102158)
124. Mufson MA, Örvell C, Rafnar B, Norrby E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 1985; 66:2111-24. (Pubitemid 15250292)
125. Sullender WM. Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev 2000; 13: 1-15. (Pubitemid 30039340)
126. Cristina J, López JA, Albo C, García-Barreno B, García J, Melero JA, et al. Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology 1990; 174: 126-34. (Pubitemid 20030958)
127. Choi E, Lee HJ. Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J Infect Dis 2000; 181: 1547-56. (Pubitemid 30387743)
128. Kuroiwa Y, Nagai K, Okita L, Tsutsumi H. Genetic Variability and Molecular Epidemiology of Respiratory Syncytial Virus Subgroup A Strains in Japan Determined by Heteroduplex Mobility Assay. J Clin Microbiol 2004; 42: 2048-53. (Pubitemid 38637822)
129. Melero JA, García-Barreno B, Martínez I, Pringle CR, Cane PA. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 1997; 78:2411-2418. (Pubitemid 27469981)
130. Cane PA, Matthews DA, Pringle CR. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol 1994; 32: 1-4. (Pubitemid 24016772)
131. Garcia O, Martin M, Dopazo J, Arbiza J, Frabasile S, Russi J, et al. Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol 1994; 68: 5448-59. (Pubitemid 24258557)
132. McCullers JA, Saito T, Iverson AR. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J Virol 2004; 78: 12817-28. (Pubitemid 39507790)
133. Viegas M, Barrero PR, Maffey AF, Mistchenko AS. Respiratory virus seasonality in children under five years of age in Buenos Aires, Argentina: a five-year analysis. J Infect 2004; 49: 222-8. (Pubitemid 39186168)
134. Gardner PS, McQuilin J. Viral diagnosis by immunofluorescence. Lancet 1968; 1: 597-8.
135. Bilkis MD, Barrero PR, Mistchenko AS. Measles resurgence in Argentina: 1997-8 outbreak. Epidemiol Inf 2000; 124: 289-93. (Pubitemid 30224138)
136. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. En: Fields Virology (Knipe DM, Howley PM, ed.) Philadelphia: Lippincott-Williams and Wilkins; 2001. pp. 1443-86.
137. Grupo colaborativo de vigilancia epidemiológica de gripe y otras virosis respiratorias en Argentina. Boletín GROG. Aventis Pasteur 2000; 4 (2).
138. Grupo colaborativo de vigilancia epidemiológica de gripe y otras virosis respiratorias en Argentina. Boletín GROG. Aventis Pasteur 2001; 5 (2).
139. World Health Organization. Weekly Epidemiological Record 2000, 75 (41).
140. World Health Organization. Weekly Epidemiological Record 2001, 76 (40).
141. Lieberman D, Lieberman D, Friger MD. Seasonal variation in hospital admissions from community-acquired pneumonia: a 5-year study. J Infect 1999; 39: 134-40.
142. Proctor DF. The mucocilliary system. In: Proctor DF, Andersen I, eds. The nose. Upper airways physiology and the atmospheric environment. Amsterdam: Elsevier; 1982; 245-78.
143. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol 2002; 122: 183-91. (Pubitemid 34270825)
144. Hambling MH. Survival of the respiratory syncytial virus during the storage under various conditions. Br J Exp Pathol 1964; 45: 647-55.
145. Rechsteiner J, Winkler KC. Inactivation of respiratory syncytial virus in aerosol. J Gen Virol 1969; 5: 405-10.
146. Hammond GW, Raddatz RL, Gelskey DE. Impact of atmospheric dispersion and transport of viral aerosols on the epidemiology of influenza. Rev Infect Dis 1989; 11: 494-7.
147. Viegas M, Mistchenko AS. Molecular epidemiology of human respiratory syncytial virus subgroup A over a six-year period (1999-2004) in Argentina. J Med Virol 2005; 77: 302-10. (Pubitemid 41285802)
148. Trento A. Viegas M, Galiano M, Videla C, Carballal G, Mistchenko AS, Melero JA.(*) contributed equally to this work. Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication. J Virol 2006; 80: 975-84. (Pubitemid 43062909)
149. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol 1998; 36: 2990-5. (Pubitemid 28429426)
150. Sullender WM, Sun L, Anderson LJ. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs. J Clin Microbiol 1993; 31: 1224-31. (Pubitemid 23129449)
151. Rajala MS, Sullender WM, Prasad AK, Dar L, Broor S. Genetic variability among Group A and B respiratory syncytial virus isolates from a large referral hospital in New Delhi, India. J Clin Microbiol 2003; 41: 2311-6. (Pubitemid 36712429)
152. Nei and Kumar. Population Trees from Genetics Markers in Nei and Kumar editors. Molecular Evolution and phylogentics. Oxford University Press 2000; 265-89.
153. Posada D, Crandall KA. 1998. Modeltest: testing the model of DNA substitution. Bioinformatics; 14: 817-8 (Pubitemid 28552116)
154. Huelsenbeck JP, Ronquist F. Bayesian inference of phylogenetic trees. Bioinformatics 2001; 17:754-755.
155. Swofford DL. PAUP*. Phylogenetic analysis using parsimony (*and other methods). Sunderland, MA: Sinauer Associates; (Version 4.0b10), 2003.
156. Scott PD, Ochola R, Ngama M, Okiro EA, Nokes DJ, Medley GF, et al. Molecular epidemiology of respiratory syncytial virus in Kilifi district, Kenya. J Med Virol 2004; 74: 344-54. (Pubitemid 39150403)
157. Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons. J Clin Microbiol 2007; 45:3022-3030. (Pubitemid 47417350)
158. Sato M, Saito R, Sakai T, Sano Y, Nishikawa M, Sasaki A, et al. Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons. J Clin Microbiol 2005; 43: 36-40. (Pubitemid 40096277)
159. Reiche J, Schweiger B. Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. J Clin Microbiol 2009; 47: 1800-10.
160. Frabasile S, Delfraro A, Facal L, Videla C, Galiano M, de Sierra MJ, et al. Antigenic and genetic variability of human respiratory syncytial viruses (group A) isolated in Uruguay and Argentina: 1993-2001. J Med Virol 2003; 71: 305-12. (Pubitemid 37048475)
161. Araùjo Moura FE, Blanc A, Frabasile S, Delfraro A, de Sierra MJ, Tome L, et al. Genetic diversity of respiratory syncytial virus isolated during an epidemic period from children of North-Eastern Brazil. J Med Virol 2004; 74: 156-60. (Pubitemid 38988873)
162. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9. (Pubitemid 47236692)
163. Baccam P, Thompson RJ, Fedrigo O, Carpenter S, Cornette JL. PAQ: Partition Analysis of Quasispecies. Bioinformatics 2001; 17: 16-22. (Pubitemid 32178010)
164. Holmes EC. Evolutionary history and phylogeography of human viruses. Review. Annu Rev Microbiol 2008; 62: 307-28.
165. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007; 7: 214-22.
166. Duffy S, Shackelton LA and Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 2008; 9: 267-76. (Pubitemid 351399833)
167. Matheson JW, Rich FJ, Cohet C, Grimwood K, Huang QS, Penny D, et al. Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. J Med Virol 2006; 78: 1354-64. (Pubitemid 44387521)
168. García-Barreno B, Palomo C, Peñas C, Delgado T, Perez- Breña P, Melero JA. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol 1989; 63: 925-32. (Pubitemid 19057262)
169. Zlateva KT, Lemey P, Moës E, Vandamme AM, Van Ranst M. Genetic Variability and Molecular Evolution of the Human Respiratory Syncytial Virus Subgroup B Attachment G Protein. J Virol 2005; 79: 9157-67. (Pubitemid 40934827)
170. Nagai K, Kamasaki H, Kuroiwa Y, Okita L, Tsutsumi H. Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides-duplicated G protein gene. J Med Virol 2004; 74: 161-5. (Pubitemid 38988874)
171. Gilca R, De Serres G, Tremblay M, Vachon ML, Leblanc E, Bergeron MG, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis 2006; 193: 54-8. (Pubitemid 43032499)
172. Parveen S, Broor S, Kapoor SK, Fowler K, Sullender WM. Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India. J Med Virol 2006; 78: 659-65.
173. Moura FE, Blanc A, Frabasile S, Delfraro A, de Sierra MJ, Tome L, et al. Genetic diversity of respiratory syncytial virus isolated during an epidemic period from children of northeastern Brazil. J Med Virol 2004; 74: 156-60. (Pubitemid 38988873)
174. Botosso VF, Zanotto PM, Ueda M, Arruda E, Gilio AE, Vieira SE, et al; VGDN Consortium. Positive Selection Results in Frequent Reversible Amino Acid Replacements in the G Protein Gene of Human Respiratory Syncytial Virus. PLoS Pathog 20085(1): e1000254. doi:10.1371.
175. Woelk CH, Holmes EC. Variable immune-drive natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol 2001; 52: 182-92. (Pubitemid 32260634)